PURE Bioscience Names CFO

San Diego-based PURE Bioscience, the developer of antimicrobial agents, said Thursday that it has named Peter C. Wulff as its Chief Financial Officer. Wulff was previously at Alphatec Holdings, and also has served at such firms as Artes Medical, CryoCor, and Natural Alternatives International. PURE Bioscience said Wulff has 25 years of experience in the industry.